|
|
Analysis of and Suggestions on the Development Situation of Tianjin Biotechnology and Related Industries |
WU Chong-ming1,3,**(),ZHANG Tuo-yu2,**(),LIU Qi2,LIU Ru1,3,CHENG Ping3 |
1 Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China 2 Tianjin Institute of Scientific & Technical Information, Tianjin 300074, China 3 National Center of Technology Innovation for Synthetic Biology, Tianjin 300308, China |
|
|
Abstract In May 2022, China issued the 14th Five-Year Plan for the Development of Bio-economy, aiming to achieve 22 trillion yuan of total bio-economy output by 2025. The development track of China’s bio-economy has shown comparative advantages of Yangtze River Delta region, Pearl River Delta region and Bohai Bay Rim region, and Sichuan and Chongqing areas have a strong momentum of catching up. Tianjin is located in the economic center of Bohai Bay Rim region and it is an important hub connecting the three Northern regions and Northeast Asia. With unique geographical advantages and profound industrial foundation, Tianjin continues to rank among the top 50 cities in terms of scientific research and metropolitan areas in the world. The development situation of biotechnology and related industries in Tianjin was deeply analyzed based on innovative resources, distribution of biotechnology industry and policy environment in Tianjin. Tianjin is rich in innovation resources of biotechnology and related industries, which is competitive on a national scale. In particular, it has strong innovation strength on research and development. It has initially formed a ‘1+5’ regional agglomeration pattern, and the overall industrial development is on the rise. At the same time, problems were analyzed, such as fierce competition among local governments, inactive capital investment and financing, and insufficient effectiveness of local technology transfer. Countermeasures and suggestions were put forward from the aspects of accelerating the cultivation of high growth track, actively exploring the integrated development mode of science and technology and capital, and further strengthening the in-depth cooperation between industries, universities and research institutes.
|
Received: 19 January 2023
Published: 01 June 2023
|
|
|
|
[1] |
Pacheco-Torgal F, Ivanov V, Tsang D. Bio-based materials and biotechnologies for eco-efficient construction. United Kingdom: Woodhead Publishing, 2020.
|
|
|
[2] |
Olaf P, Nicolas H, Michael C, et al. European Bioeconomy in Figures 2008-2019. Hürth Germany: Nova-Institute for Ecology and Innovation, 2022: 4-5.
|
|
|
[3] |
央视网. 《“十四五”生物经济发展规划》发布 2025年我国生物经济总量有望达22万亿元. [2022-05-10]. https://tv.cctv.com/2022/05/10/VIDEMPrrVFm0HQwgatH6I1hn220510.shtml.
|
|
|
[3] |
www.cctv.com. The 14th Five-Year Plan for the Development of Biological Economy was released that China’s biological economy is expected to reach 22 trillion yuan by 2025. [2022-05-10]. https://tv.cctv.com/2022/05/10/VIDEMPrrVFm0HQwgatH6I1hn220510.shtml.
|
|
|
[4] |
丁陈君, 陈方, 韩祺, 等. 国外生物经济规模测算方法分析及对我国的启示. 中国生物工程杂志, 2022, 42(5): 154-162.
|
|
|
[4] |
Ding C J, Chen F, Han Q, et al. Methodology for measuring bioeconomy in some countries/regions and its enlightenment to China. China Biotechnology, 2022, 42(5): 154-162.
|
|
|
[5] |
Nature. Science cities 2022. [2022-11-25]. https://www.nature.com/collections/science-cities-index-2022.
|
|
|
[6] |
Soumitra D, Bruno L, Lorena R, et al. Globle Innovation Index 2022: What is the future of innovation-driven growth? Switzerland: World Intellectual Property Organization, 2022: 58.
|
|
|
[7] |
Wu Y B, Wu S P, Hou L H, et al. Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e V, 2012, 81(3): 486-497.
|
|
|
[8] |
国家药品监督管理局. 国家药监局附条件批准康希诺生物股份公司重组新型冠状病毒疫苗(5型腺病毒载体)注册申请. [2021-02-25]. https://www.nmpa.gov.cn/zhuanti/yqyjzxd/yqyjxd/20210225184523188.html.
|
|
|
[8] |
National Medical Products Administration (NMPA). NMPA conditionally approved the registration application of the recombinant novel coronavirus vaccine (adenovirus type 5 vector) by Consino Bio. [2021-02-25]. https://www.nmpa.gov.cn/zhuanti/yqyjzxd/yqyjxd/20210225184523188.html.
|
|
|
[9] |
国家药品监督管理局. 植入式左心室辅助系统获批上市. [2022-07-13]. https://www.nmpa.gov.cn/ylqx/ylqxjgdt/20220713171821131.html.
|
|
|
[9] |
National Medical Products Administration (NMPA). Implantable left ventricular assist system approved for marketing. [2022-07-13]. https://www.nmpa.gov.cn/ylqx/ylqxjgdt/20220713171821131.html.
|
|
|
[10] |
Wu Y, Li B Z, Zhao M, et al. Bug mapping and fitness testing of chemically synthesized chromosome X. Science, 2017, 355(6329): eaaf4706.
doi: 10.1126/science.aaf4706
|
|
|
[11] |
Xie Z X, Li B Z, Mitchell L A, et al. Perfect designer chromosome V and behavior of a ring derivative. Science, 2017, 355(6329): eaaf4704.
|
|
|
[12] |
Shen Y, Wang Y, Chen T, et al. Deep functional analysis of synII, a 770-kilobase synthetic yeast chromosome. Science, 2017, 355(6329): eaaf4791.
|
|
|
[13] |
Zhang W M, Zhao G H, Luo Z Q, et al. Engineering the ribosomal DNA in a megabase synthetic chromosome. Science, 2017, 355(6329): eaaf3981.
|
|
|
[14] |
Cai T, Sun H B, Qiao J, et al. Cell-free chemoenzymatic starch synthesis from carbon dioxide. Science, 2021, 373(6562): 1523-1527.
doi: 10.1126/science.abh4049
pmid: 34554807
|
|
|
[15] |
科技部. 《2022中国生物医药产业园区竞争力评价及分析报告》正式发布. [2022-11-09]. https://www.most.gov.cn/kjbgz/202211/t20221109_183363.html.
|
|
|
[15] |
Ministry of Science and Technology of PRC. “Report on Competitiveness Evaluation and Analysis of China Biomedical Industrial Park 2022” released. [2022-11-09]. https://www.most.gov.cn/kjbgz/202211/t20221109_183363.html.
|
|
|
[16] |
国家发展和改革委员会创新和高技术发展司,中国生物工程学会. 中国生物产业发展报告2019. 北京: 化学工业出版社, 2020: 342-348.
|
|
|
[16] |
Department of Innovation and High Technology Development, National Development and Reform Commission, Chinese society of biotechnology. China biological industry development report 2019. Beijing: Chemical Industry Press, 2020: 342-348.
|
|
|
[17] |
天津市工业和信息化局. 天津市生物医药产业发展“十四五”专项规划. [2021-11-01]. https://gyxxh.tj.gov.cn/ZWGK4147/ZCWJ6355/wjwj/202111/t20211112_5702172.html.
|
|
|
[17] |
Tianjin Industrial and Information Technology Bureau. Tianjin biopharmaceutical industry development “14th Five-Year” special plan. [2021-11-01]. https://gyxxh.tj.gov.cn/ZWGK4147/ZCWJ6355/wjwj/202111/t20211112_5702172.html.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|